-
GH Research Shares Q2 2022 Financial Results & Business Updates
Tuesday, August 23, 2022 - 4:10pm | 501GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial and business update for the quarter ended June 30, 2022. The financial results for the...